Corneal cross‑linking is a treatment designed to strengthen the cornea when it begins to thin or weaken. The procedure uses special eye drops and light to help the corneal tissue become firmer and more stable over time. Its main purpose is to slow or stop the progression of conditions that can cause the cornea to bulge or distort, helping protect vision and reduce the need for more invasive treatments later on.
Cross Linking is a treatment that strengthens the cornea to prevent further thinning or bulging. The most common reason for cross linking is Keratoconus, a condition that causes the cornea to weaken and distort vision. This procedure uses riboflavin (vitamin B2) drops and UV light to stabilize the cornea and help slow or stop the progression of keratoconus.




We’re so excited that Glaukos has partnered with NBA Champion Stephen Curry to raise awareness for keratoconus (KC). We are proud to support this initiative that encourages more people to recognize the signs and symptoms of KC, ask questions, and prioritize their eye health. Keratoconus, or KC, is a sight-threatening eye disease in which the cornea weakens and thins over time, causing blurry or distorted vision. With early diagnosis and treatment intervention, it's possible to preserve more of your vision. We remain committed to advancing care with teamwork, innovation, and a focus on patients.
Learn about Stephen’s personal journey living with keratoconus and more at CoulditbeKC.com